“…Histologic findings of myxomatous valvular disease include highly fragmented collagen within the valve fibrosa and excess accumulation of GAGs, which causes billowing of the valve leaflets, with or without prolapse and regurgitation of mitral or aortic valves [11,12,13]. Regardless of the classification of valve disease, the valve thickening is often an early and major clinical complication of cardiac valve dysfunction in neonatal/infantile and adult patients with inherited (bicuspid aortic valve or congenital polyvalvular disease) or acquired conditions, including Marfan syndrome-like disorders, Noonan syndrome, isolated non-syndromic X-linked myxomatous valvular dystrophy, rheumatic arthritis, and anti-Parkinson's disease drug-induced (dopamine agonists, i.e., pergolide and cabergoline) valvular disease [14,15,16,17,18,19,20]. At the molecular and genetic levels, periostin and transforming growth factor beta (TGF) and bone morphogenetic protein (BMP) ligands have emerged as important players in heart valve formation and remodeling, and valvular heart diseases in mammals [21,22,23,24,25] ( Fig.…”